BeOne Medicines (ONC) Construction in Progress (2016 - 2026)

BeOne Medicines (ONC) has 10 years of Construction in Progress data on file, last reported at $137.4 million in Q1 2026.

• On a quarterly basis, Construction in Progress fell 76.7% year-over-year to $137.4 million in Q1 2026; TTM through Mar 2026 was $137.4 million, a 76.7% decrease from a year earlier, with the FY2025 full-year figure at $127.2 million, down 80.56% from the prior year.
• Construction in Progress for Q1 2026 stood at $137.4 million, up from $127.2 million in the prior quarter.
• Over the last five years, Construction in Progress for ONC reached as high as $863.4 million in Q2 2024 and fell as low as $127.2 million in Q4 2025.
• Historically, Construction in Progress has averaged $447.9 million across 5 years, with a median of $430.6 million in 2023.
• Across the five-year window, Construction in Progress surged 184.02% in 2023 and sank 80.56% in 2025, its largest moves.
• Year by year, Construction in Progress stood at $293.6 million in 2022, then jumped by 152.23% to $740.6 million in 2023, then slipped by 11.69% to $654.0 million in 2024, then sank by 80.56% to $127.2 million in 2025, then gained by 8.09% to $137.4 million in 2026.
• Per Business Quant data, the three most recent Construction in Progress figures were $137.4 million in Q1 2026, $127.2 million in Q4 2025, and $129.1 million in Q3 2025.